Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Porcine pancreas elastase** is a **serine protease enzyme** purified from pig pancreas, belonging to the chymotrypsin family. It hydrolyzes proteins by cleaving peptide bonds at the carboxyl side of small hydrophobic amino acids (including Ile, Gly, Ala, Ser, Val, and Leu), as well as amides and esters. It is a **single polypeptide chain of 240 amino acids** and contains four disulfide bridges. The enzyme is synthesized as an inactive zymogen and activated by proteolysis. Porcine pancreas elastase is widely used as a **biochemical reagent (in research and diagnostics)** and as a model enzyme for human leukocyte elastase in drug development. It is not itself a marketed pharmaceutical nor used directly as a therapeutic agent. Its main applications include induction of abdominal aortic aneurysm in animal models, studies on elastase inhibitors, and as a reference in pancreatic enzyme testing[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on porcine pancreas elastase.